Dr. Acharya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 W 10th Ave
Columbus, OH 43210Phone+1 614-293-5066Fax+1 614-293-9449
Summary
Clinical Expertise
- Hematology, Medical oncology, Adoptive immunotherapy, Hematologic oncology, Leukemia, Lymphoma, Multiple myeloma, Myelodysplasia, Myelofibrosis, T-cell adoptive tumor therapy, Acute myeloid leukemia
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2012 - 2015
- Ohio State University HospitalResidency, Internal Medicine, 2010 - 2012
- University of South Florida MorsaniInternship, Internal Medicine, 2009 - 2010
- Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2009
- Wilmington CollegeB.S, Major: Biology/ Minor: Chemistry, 2004
Certifications & Licensure
- MA State License 2018 - 2025
- OH State License 2010 - 2025
- WA State License 2016 - 2025
- AZ State License 2012 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians, 2015
- Member Alpha Omega Medical Honor Society
- Member Arnold P Gold Humanism Honor Society
Publications & Presentations
PubMed
- 41 citationsAllogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.Joanna Zurko, Jeremy Ramdial, Mazyar Shadman, Sairah Ahmed, Aniko Szabo
Haematologica. 2023-01-01 - 220 citationsThe response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay, Jenna M. Voutsinas, Qian Wu
Blood. 2019-04-25 - 66 citationsRisk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled TrialsSeongseok Yun, Nicole D. Vincelette, Utkarsh Acharya, Ivo Abraham
Clinical Lymphoma, Myeloma & Leukemia. 2017-01-01
Journal Articles
- DVT prophylaxis in long term care facilities - perhaps less is more.Acharya U, Khan S, Journal of American Medical Directors Association;12(4):313
- Teretocarcinoma in a Young Man with Testicular Torsion.Acharya U, Stroble S, Pepe L, Miocinovic R, Journal of histotechnology
- It doesn’t matter which sex students are.Acharya, U, studentBMJ ;14:89
Books/Book Chapters
Abstracts/Posters
- Does Gastric Acid Suppressive Therapy Increase the Risk of Pneumonia in Older Adults?Gau J-T, Acharya U, Kao T, Khan S, Moy J, Carlsen W, Journal of American Geriatrics Society. Annual Meeting Abstract Supplement, Seattle, WA
- Effects of Eukarytoic Cell Cycle Inhibitors on Toxoplasma gondii.Acharya U, Woodmansee, D, Annual Biomedical Research Conference for Medical Students, San Diego, CA
- Effects of Ca2+/K+ flux on Trypanosoma cruzii Egress.Acharya U, Rowland E, Ohio University College of Osteopathic Medicine, Athens, OH
- Join now to see all
Other
- The Malignancies of Medicine.Acharya U, The Yale Journal for Humanities in Medicine.
http://yjhm.yale.edu/ - Am I going crazy?Acharya and U
http://www.mdconsult.com
Authored Content
- The COVID-19 Conundrum & Cancer - Making Perfect Sense of Imperfect DataMay 2020
Press Mentions
- Dr. Utkarsh Acharya: On the Challenges, Pride and Frustrations of Treating CAR-T PatientsNovember 12th, 2018
- Dr. Utkarsh Acharya: On “Why Become Involved in Immunotherapy and Cellular Therapies for Treating Cancer?”October 27th, 2018
- Part 2: Why Seattle for My CAR-T Therapy to Demolish My CLL?April 5th, 2018
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Gujarati
Industry Relationships
- Medical Director, Bristol Myers SquibbMedical director in the cell therapy group of Bristol Myers Squibb.2022 - 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: